Kung Winston
SEC Form 4 insider trading activity
Kung Winston has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including JANX, CRBP, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jun 13, 2026.
On the most recent filing, Kung Winston is listed as Director at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Kung Winston reported no open-market purchases and 1 open-market sale totaling $16K in CRBP.
Companies traded
Other insiders at JANX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$16K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kung Winston made?
Kung Winston has filed 3 SEC Form 4 filings (3 transaction rows) across 2 companies, including JANX, CRBP since 2026.
Which companies does Kung Winston trade?
Kung Winston has filed SEC Form 4 disclosures for 2 companies, including JANX, CRBP.
When was Kung Winston's most recent SEC Form 4 filing?
Kung Winston's most recent SEC Form 4 filing on Tracefour is dated Jun 13, 2026.
What is Kung Winston's total buy and sell value in the current window?
Inside the rolling retention window, Kung Winston bought $0 and sold $16K based on SEC Form 4 filings.
What was Kung Winston's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,026 CRBP shares on 2026-06-10, worth $16K, per SEC Form 4 filings.